Piramal Pharma Solutions (PPS) is a global CDMO under Piramal Pharma Limited, offering end-to-end development and manufacturing solutions across the drug lifecycle. Operates through a globally integrated network of 17 development and manufacturing facilities across North America, Europe, and Asia, with distribution in 100+ countries. Services include drug discovery, process/pharmaceutical development, clinical trial supplies, and commercial supply of APIs and finished dosage forms. Specialized in highly potent APIs, antibody-drug conjugations, sterile fill/finish, and peptide products. Multiple CDMO Leadership Award winner.
End-to-end drug development, highly potent API manufacturing, ADC conjugation, sterile fill/finish, peptide manufacturing, potent solid oral drug products, drug discovery services, inhaled anesthetics
6 sites worldwide
No reviews available yet.
No documents available.